238 related articles for article (PubMed ID: 33978827)
1. Cystatin C: best biomarker for acute kidney injury and estimation of glomerular filtration rate in childhood cirrhosis.
Vijay P; Lal BB; Sood V; Khanna R; Alam S
Eur J Pediatr; 2021 Nov; 180(11):3287-3295. PubMed ID: 33978827
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for acute kidney injury in decompensated cirrhosis: A prospective study.
Jaques DA; Spahr L; Berra G; Poffet V; Lescuyer P; Gerstel E; Garin N; Martin PY; Ponte B
Nephrology (Carlton); 2019 Feb; 24(2):170-180. PubMed ID: 29369449
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
Palazzuoli A; Ruocco G; Pellegrini M; De Gori C; Del Castillo G; Franci B; Nuti R; Ronco C
Am J Cardiol; 2015 Jul; 116(1):104-11. PubMed ID: 25943992
[TBL] [Abstract][Full Text] [Related]
4. Plasma NGAL predicts early acute kidney injury no earlier than s-creatinine or cystatin C in severely burned patients.
Rakkolainen I; Vuola J
Burns; 2016 Mar; 42(2):322-8. PubMed ID: 26724852
[TBL] [Abstract][Full Text] [Related]
5. Value of urinary KIM-1 and NGAL combined with serum Cys C for predicting acute kidney injury secondary to decompensated cirrhosis.
Lei L; Li LP; Zeng Z; Mu JX; Yang X; Zhou C; Wang ZL; Zhang H
Sci Rep; 2018 May; 8(1):7962. PubMed ID: 29784944
[TBL] [Abstract][Full Text] [Related]
6. Urinary neutrophil gelatinase-associated lipocalin (NGAL) and serum cystatin C measurements for early diagnosis of acute kidney injury in children admitted to PICU.
Kari JA; Shalaby MA; Sofyani K; Sanad AS; Ossra AF; Halabi RS; Aljuhani MH; Toffaha WM; Moria FA; Sabry S; Ahmed HA; Alhasan KA; Sharief S; Safdar O
World J Pediatr; 2018 Apr; 14(2):134-142. PubMed ID: 29464581
[TBL] [Abstract][Full Text] [Related]
7. Serum Neutrophil Gelatinase-Associated Lipocalin and Cystatin C for Assessing Recovery of Graft Function in Patients Undergoing Living-Donor Kidney Transplantation.
Liu Y; Li HX; Ying ZW; Guo JJ; Cao CY; Jia W; Yang HR
Clin Lab; 2016; 62(1-2):155-63. PubMed ID: 27012045
[TBL] [Abstract][Full Text] [Related]
8. Assessment of biochemical markers in the early post-burn period for predicting acute kidney injury and mortality in patients with major burn injury: comparison of serum creatinine, serum cystatin-C, plasma and urine neutrophil gelatinase-associated lipocalin.
Yang HT; Yim H; Cho YS; Kym D; Hur J; Kim JH; Chun W; Kim HS
Crit Care; 2014 Jul; 18(4):R151. PubMed ID: 25023056
[TBL] [Abstract][Full Text] [Related]
9. Serum Cystatin C as an Early Marker of Neutrophil Gelatinase-associated Lipocalin-positive Acute Kidney Injury Resulting from Cardiopulmonary Bypass in Infants with Congenital Heart Disease.
Herbert C; Patel M; Nugent A; Dimas VV; Guleserian KJ; Quigley R; Modem V
Congenit Heart Dis; 2015; 10(4):E180-8. PubMed ID: 25727405
[TBL] [Abstract][Full Text] [Related]
10. Predicting the development of acute kidney injury in liver cirrhosis--an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers.
Slack AJ; McPhail MJ; Ostermann M; Bruce M; Sherwood R; Musto R; Dew T; Auzinger G; Bernal W; O'Grady J; Heneghan MA; Moore K; Wendon JA
Aliment Pharmacol Ther; 2013 May; 37(10):989-97. PubMed ID: 23577724
[TBL] [Abstract][Full Text] [Related]
11. Serum cystatin C, kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, klotho and fibroblast growth factor-23 in the early prediction of acute kidney injury associated with sepsis in a Chinese emergency cohort study.
Pei Y; Zhou G; Wang P; Shi F; Ma X; Zhu J
Eur J Med Res; 2022 Mar; 27(1):39. PubMed ID: 35272698
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Cystatin C and NGAL in Early Diagnosis of Acute Kidney Injury After Heart Transplantation.
Hošková L; Franekova J; Málek I; Kautzner J; Szárszoi O; Jabor A; Pinďák M; Viklický O; Melenovský V
Ann Transplant; 2016 May; 21():329-245. PubMed ID: 27226081
[TBL] [Abstract][Full Text] [Related]
13. Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study.
Sinna MM; Altaf FMN; Mosa OF
Curr Pharm Des; 2019; 25(10):1122-1133. PubMed ID: 31096894
[TBL] [Abstract][Full Text] [Related]
14. Baseline serum cystatin C as a marker of acute kidney injury in patients with acute-on-chronic liver failure.
Jha P; Jha AK; Dayal VM; Jha SK; Kumar A
Indian J Gastroenterol; 2021 Dec; 40(6):563-571. PubMed ID: 34981441
[TBL] [Abstract][Full Text] [Related]
15. Cystatin C in acute kidney injury diagnosis: early biomarker or alternative to serum creatinine?
Lagos-Arevalo P; Palijan A; Vertullo L; Devarajan P; Bennett MR; Sabbisetti V; Bonventre JV; Ma Q; Gottesman RD; Zappitelli M
Pediatr Nephrol; 2015 Apr; 30(4):665-76. PubMed ID: 25475610
[TBL] [Abstract][Full Text] [Related]
16. Serum Cystatin C, Klotho, and Neutrophil Gelatinase-Associated Lipocalin in the Risk Prediction of Acute Kidney Injury after Acute Myocardial Infarction.
Pei Y; Chen W; Mao X; Zhu J
Cardiorenal Med; 2020; 10(6):374-381. PubMed ID: 33017825
[TBL] [Abstract][Full Text] [Related]
17. Serum NGAL, cystatin C and urinary NAG measurements for early diagnosis of contrast-induced nephropathy in children.
Benzer M; Alpay H; Baykan Ö; Erdem A; Demir IH
Ren Fail; 2016; 38(1):27-34. PubMed ID: 26584598
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
Liebetrau C; Gaede L; Doerr O; Blumenstein J; Rixe J; Teichert O; Willmer M; Weber M; Rolf A; Möllmann H; Hamm C; Nef H
Scand J Clin Lab Invest; 2014 Mar; 74(2):81-8. PubMed ID: 24304491
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C predicts acute kidney injury and mortality in cirrhotics: A prospective cohort study.
Maiwall R; Kumar A; Bhardwaj A; Kumar G; Bhadoria AS; Sarin SK
Liver Int; 2018 Apr; 38(4):654-664. PubMed ID: 28941301
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of biomarkers in the diagnosis of acute kidney injury secondary to liver cirrhosis.
Yang Y; Ge B; Liu Y; Feng J
Medicine (Baltimore); 2021 Apr; 100(14):e25411. PubMed ID: 33832138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
